Ethical issues in adapting new technologies for rapid diagnosis.
Indian J Med Ethics
;
2013 Oct-Dec;10 (4): 254-255
Artigo
em Inglês
| IMSEAR
| ID: sea-181218
ABSTRACT
he Xpert® MTB/RIF (hereafter Xpert) is a recent technology that has “demonstrated sensitive detection of tuberculosis (TB) and rifampicin resistance directly from untreated sputum in less than two hours” . Many are in favour of the widespread implementation of this technology in India. In a recent article in the IJME, Singh, Bhan and Upshur state that “India is ethically obliged to phase in the nationwide deployment of Xpert…as soon as reasonably possible” and “is ethically obliged to provide those diagnosed with first-line drug resistance universal access to second-line TB drugs” to treat multiple drug-resistant tuberculosis (MDR-TB) .
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Tipo de estudo:
Estudo diagnóstico
Idioma:
Inglês
Revista:
Indian J Med Ethics
Assunto da revista:
Ethics
Ano de publicação:
2013
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS